Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)

Recruiting now

Conditions studied: Prostate Adenocarcinoma

In brief

This study evaluates the possibility of patient-centered home care as a new model of cancer care to reduce disparities and improve health related quality of life and patient-reported outcomes in Black patients with prostate cancer.

Key facts

Study ID

NCT06470750

Run by

Mayo Clinic

People needed

77

Starts

2024-07-25

Expected to finish

2026-07-30

Last updated by the study team

2026-01-20

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• GROUP 1 FOCUS GROUPS:
• Individuals identifying as Black and male who are familiar with the landscape of medical care and cancer
• GROUP 1 SURVEYS:
• Are 18 years of age or older
• Have histologic evidence of prostate adenocarcinoma
• Are requiring, have required, or will require prostate cancer treatment
• Have an understanding of the protocol and its requirements
• Are willing to fill in a questionnaire and participate in a focused interview
• Are able and willing to sign an informed consent
• GROUP 1 INTERVIEWS:
• Enrollment in the survey phase of the protocol
• GROUP 2:
• Are 18 years of age or older
• Are Black men or other discounted patients (older adults, individuals residing in rural or remote areas, and those facing transportation challenges)
• Have histologic evidence of prostate adenocarcinoma
• Are requiring active standard hormone-based therapies (degarelix or leuprolide), antibone resorptive agents (zoledronic acid or denosumab), oral anticancer treatments (abiraterone or second-generation androgen receptor blockers) or intravenous chemotherapy (docetaxel)
• Are receiving part of supportive care/symptom management and/or anti-cancer therapy in the home as part of Cancer Care Beyond Walls (CCBW)
• Have an understanding of the protocol and its requirements
• Are able and willing to sign informed consent

You may not qualify if…

• GROUP 1 FOCUS GROUPS:
• Individuals who do not identify as Black or male or who have had no extensive interaction with the healthcare system
• GROUP 1 SURVEYS:
• Do not identify as Black men
• Have not been diagnosed with prostate cancer
• GROUP 1 INTERVIEWS:
• Not enrolled in the survey phase of the protocol
• GROUP 2:
• Do not identify as Black men or other discounted patients (older adults, individuals residing in rural or remote areas, and those facing transportation challenges)
• Have not been diagnosed with histologic evidence of prostate adenocarcinoma
• Are not requiring active standard anti-cancer therapy

Where it is running

• Mayo Clinic in Florida — Jacksonville, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.